ABSTRACT
Introduction Hypoxaemia (low blood oxygen) is common among hospitalised patients, increasing risk of death five-fold and requiring prompt detection and treatment. However, we know little about hypoxaemia prevalence in primary care and the role for pulse oximetry and oxygen therapy. This study assessed the prevalence and management of hypoxaemia at primary care facilities in Uganda.
Methods Prospective cohort study in 30 primary care facilities in Uganda, Feb-Apr 2021. Clinical data collectors assessed blood oxygen level (SpO2) of all acutely unwell children, adolescents, and adults, and followed up children aged under 15 years with SpO2<93% to determine subsequent care and outcome. Primary outcome: proportion of children under 5 years of age with severe hypoxaemia (SpO2<90%). Secondary outcomes: severe/moderate hypoxaemia (SpO2 90-93%) by age/sex/complaint.
Results Among children U5, the prevalence of severe hypoxaemia was 1.3% (95% CI 0.9 to 2.1); an additional 4.9% (3.9 to 6.1) had moderate hypoxaemia. Performing pulse oximetry according to World Health Organization guidelines exclusively on children with respiratory complaints would have missed 14% (3/21) of severe hypoxaemia and 11% (6/55) of moderate hypoxaemia. Hypoxaemia prevalence was low among children 5-14 years (0.3% severe, 1.1% moderate) and adolescents/adults 15+ years (0.1% severe, 0.5% moderate). A minority (12/27, 44%) of severely hypoxaemic patients were referred; 3 (12%) received oxygen.
Conclusion Hypoxaemia is common among acutely unwell children under five years of age presenting to Ugandan primary care facilities. Routine pulse oximetry has potential to improve referral, management and clinical outcomes. Effectiveness, acceptability, and feasibility of pulse oximetry and oxygen therapy for primary care should be investigated in implementation trials.
What is already known?
Hypoxaemia (low blood oxygen levels) is common among children and adults admitted to hospital with severe respiratory illness, increasing their risk of death at least 5-fold and requiring prompt detection and treatment.
We know little about the prevalence of hypoxaemia in primary care, or whether pulse oximetry would improve decision-making or care for hypoxaemic patients.
What are the new findings?
In a Ugandan primary care context, hypoxaemia was common among acutely unwell children under five years of age and most were not referred to hospital for treatment.
Hypoxaemia was uncommon among older children and adults presenting to Ugandan primary care facilities but prevalence increased with age into older adulthood.
What do the new findings imply?
Routine pulse oximetry screening may be warranted for acutely unwell children under five years of age, with a potential to improve referral, management and clinical outcomes.
Effectiveness, acceptability, and feasibility of pulse oximetry and oxygen therapy for primary care should be investigated in further implementation trials.
Competing Interest Statement
HG is an advisor to the Lifebox Foundation, UNICEF, and Unitaid on pulse oximetry. YK, JM, BK, SE, LK, FL are employed by CHAI who are implementing the oxygen program in Uganda. CO works for the Federal Ministry of Health which provides funding and oversight for health facilities.
Funding Statement
This study was funded by a grant from the Bill and Melinda Gates Foundation (BMGF) INV-001132 and ELMA Philanthropies. Any views or opinions presented are solely those of the author and do not necessarily represent those of BMGF or ELMA, unless otherwise specifically stated. The funder was not involved in the writing of this manuscript or decision for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study has received ethical approval from the Research Ethics Committee at: Makerere University College of Health Sciences (#SHSREC Ref No.: 2020-030) and clearance and registration by the Uganda National Council of Science and Technology, reference number (HS631ES).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: Hamish.graham{at}rch.org.au; ykamuntu{at}clintonhealthaccess.org; jmiller{at}clintonhealthaccess.org; abarrett{at}unimelb.edu.au; bkunihira{at}clintonhealthaccess.org; sengol{at}clintonhealthaccess.org; lkabunga{at}clintonhealthaccess.org; flam{at}clintonHealthAccess.org; olarocharles{at}gmail.com; harrietajilong{at}gmail.com; kitutufred{at}gmail.com
Data Availability
All relevant data for this study is included in the manuscript and supplemental files.